The short answer: delayed stomach emptying from GLP-1 therapy may reduce oral contraceptive absorption, making backup contraception a practical consideration
The most common gastrointestinal side effects include: Nausea : Reported in 15-44% of patients (higher rates at Wegovy 2.4 mg), typically most pronounced during dose escalation Diarrhea : Affects approximately 8-30% of users, ranging from mild to moderate severity Vomiting : Occurs in 5-24% of patients (higher rates at Wegovy 2.4 mg), often associated with rapid dose increases Abdominal pain : Experienced by 5-20% of patients, usually described as cramping or discomfort Constipation : Paradoxically affects 3-24% despite the medication's effects on motility Dyspepsia and gastroesophageal reflux : Related to delayed gastric emptying These effects result from semaglutide's pharmacologic action on GLP-1 receptors throughout the gastrointestinal tract
What to Expect from Skin Tightening Treatments in San Diego Comprehensive Evaluation Your consultation begins with a detailed assessment performed by a board-certified dermatologist
Mail-order pharmacies, PBMs and insurers save money by channeling millions of prescriptions through centralized operations
No significant heterogeneity was observed
Wegovy is started at a low dose and gradually increased over 16 to 20 weeks